Immediate Impact

37 standout
Sub-graph 1 of 17

Citing Papers

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
2 intermediate papers

Works of Jihad Inshasi being referenced

Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review
2020
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks
2016

Author Peers

Author Last Decade Papers Cites
Jihad Inshasi 458 175 99 131 66 678
Jasem Al–Hashel 558 208 151 121 66 829
Derrick Robertson 439 228 73 130 45 771
Julia O’Mahony 558 308 139 98 40 796
Pål Berg‐Hansen 453 142 115 68 40 664
Rachel Farrell 345 132 140 160 43 722
Xiaojun You 627 226 247 212 50 815
Annette Wundes 532 154 94 256 34 791
Rosa Ruchlemer 290 50 56 135 48 712
Sibyl Wray 426 169 97 151 57 600
Paolo Immovilli 364 365 48 120 44 801

All Works

Loading papers...

Rankless by CCL
2026